Abstract | BACKGROUND: STUDY DESIGN: Participants were 997 persons 77 to 100 yr old enrolled in the Cardiovascular Health Study All Stars Study. Plasma levels of IGF-I, IGFBP-1, and IGFBP-3 were assessed at two study examinations (1996-1997 and 2005-2006). Mortality was assessed between 2006 and 2010. RESULTS: Cumulative mortality (CM) was similar among individuals who had at least 10% decreases over time in IGF-I levels (CM = 29.6%), individuals who had at least 10% increases over time in IGF-I levels (CM = 24.7%), and individuals who had IGF-I levels remaining within ±10% over time (CM = 23.5%). Adjusted for age, sex, race, diabetes, body mass index, creatinine, albumin, and C-reactive protein, decreasing IGF-I level had no significant association with overall cancer mortality or noncancer mortality. Levels of IGFBP-1 increased markedly over time by 38% (median). Individuals with the largest increases in IGFBP-1 level over time had significantly increased risk of mortality. The adjusted hazard ratio per sd of IGFBP-1 change was 1.40 for overall cancer mortality (95% confidence interval = 1.10, 1.77; P = 0.01) and 1.14 for noncancer mortality (95% confidence interval = 1.02, 1.27; P = 0.02). Changes in IGFBP-3 levels were not significantly associated with mortality. CONCLUSION: Among older adults, decreasing IGF-I level over time does not predict subsequent all-cause mortality, whereas increasing IGFBP-1 predicts increased risk of mortality.
|
Authors | Robert C Kaplan, Petra Bùzková, Anne R Cappola, Howard D Strickler, Aileen P McGinn, Laina D Mercer, Alice M Arnold, Michael N Pollak, Anne B Newman |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 97
Issue 6
Pg. 1970-6
(Jun 2012)
ISSN: 1945-7197 [Electronic] United States |
PMID | 22442270
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- IGFBP1 protein, human
- IGFBP3 protein, human
- Insulin-Like Growth Factor Binding Protein 1
- Insulin-Like Growth Factor Binding Protein 3
- Insulin-Like Growth Factor I
|
Topics |
- Aged
- Aged, 80 and over
- Black People
(statistics & numerical data)
- Cardiovascular Diseases
(blood, mortality)
- Female
- Follow-Up Studies
- Humans
- Insulin-Like Growth Factor Binding Protein 1
(blood)
- Insulin-Like Growth Factor Binding Protein 3
(blood)
- Insulin-Like Growth Factor I
(metabolism)
- Longitudinal Studies
- Male
- Mortality
(trends)
- Predictive Value of Tests
- Risk Factors
- White People
(statistics & numerical data)
|